I would think he is talking about the metal isnt in a bubble its the market and the amount of "explorers out there on the ASX" that will ultimately cause a bubble with high valuations PLS was at 100m market cap with a 45mt resource these companies these days are at 200m+ with a few drill results and alot of excitement and enthusiasm that defies logic. Eg Iron ore boom how many companies disappeared when the market realized who was the pretenders and who were the diamonds.
@HappyCats
what do you think of the following comment fro JL
"If you go out to 2025, it gets harder to achieve the 50 percent because the demand growth rate steps up and they’re going to be out of potential capacity in Chile by then. The Atacama won’t, in all likelihood, support more than the volumes contemplated in their MOU with CORFO plus what SQM does. Yes, there is more lithium value potential in the Atacama, but there are water limitations and a lot of other issues that will ultimately hinder further development."
- Forums
- ASX - By Stock
- PLS
- Thesi’s soapbox questions for Ken Brinsden
Thesi’s soapbox questions for Ken Brinsden, page-26
-
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 329137 | 3.020 |
23 | 502241 | 3.010 |
92 | 359053 | 3.000 |
16 | 98735 | 2.990 |
19 | 101042 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 32598 | 6 |
3.050 | 109743 | 7 |
3.060 | 104622 | 7 |
3.070 | 137237 | 8 |
3.080 | 1849 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online